{"id":"NCT03294538","sponsor":"Actavis Inc.","briefTitle":"Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace速 Cream 0.01% in Atrophic Vaginitis","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Estradiol Vaginal Cream USP, 0.01% (Teva Pharmaceuticals, USA) to Estrace速 Estradiol Vaginal Cream, USP, 0.01% (Warner Chilcott) in the Treatment of Atrophic Vaginitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-05-18","primaryCompletion":"2017-02-15","completion":"2017-02-15","firstPosted":"2017-09-27","resultsPosted":"2019-12-26","lastUpdate":"2019-12-26"},"enrollment":663,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Atrophic Vaginitis"],"interventions":[{"type":"DRUG","name":"Generic Estradiol Vaginal Cream USP, 0.01%","otherNames":[]},{"type":"DRUG","name":"Estrace速 Vaginal Cream USP, 0.01%","otherNames":[]},{"type":"DRUG","name":"Vehicle Vaginal Cream","otherNames":[]}],"arms":[{"label":"Generic Estradiol Vaginal Cream USP, 0.01%","type":"EXPERIMENTAL"},{"label":"Estrace Vaginal Cream USP, 0.01%","type":"ACTIVE_COMPARATOR"},{"label":"Vehicle Vaginal Cream","type":"PLACEBO_COMPARATOR"}],"summary":"The objectives of this study were to evaluate the therapeutic equivalence of the Test formulation, generic Estradiol Vaginal Cream United States Pharmacopoeia (USP), 0.01% (Teva Pharmaceuticals, United States of America) to the marketed product, Estrace速 Cream estradiol vaginal cream USP, 0.01% (Warner Chilcott) in participants with atrophic vaginitis; to demonstrate the superiority of the Test and Reference (active) treatments over Placebo (vehicle) cream in participants with atrophic vaginitis; and to compare the safety of Test, Reference, and Placebo treatments in participants with atrophic vaginitis.","primaryOutcome":{"measure":"Number of Participants Identified as a Responder After Completing Study Treatment in the Generic Estradiol Vaginal Cream and Estrace Vaginal Cream Groups","timeFrame":"Up to Day 9","effectByArm":[{"arm":"Generic Estradiol Vaginal Cream USP, 0.01%","deltaMin":49,"sd":null},{"arm":"Estrace Vaginal Cream USP, 0.01%","deltaMin":44,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"30 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":null},"locations":{"siteCount":44,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":267},"commonTop":["Breast tenderness","Abdominal pain","Abdominal distension","Headache","Abdominal pain lower"]}}